Meeting abstracts
AAD 2026
American Academy of Dermatology · Denver, 27–31 March 2026
1,877 abstracts, published in JAAD on 6 July 2026. Their text is on the JAAD website.
- 71096
A Qualitative Study to Support the Content Validity of the Cutaneous Lupus Activity Investigator’s Global Assessment Revised (CLA-IGA-R): Clinician Perspectives
Merola J, Yang W, … senior author Zeng F
- 71101
- 71118
A questionnaire-based survey to determine knowledge, attitude, and practice of use of rituximab by Indian dermatologists in pemphigus
De D, Baskaran N, … senior author Handa S
- 71145
A Rare Case of Radiation-Induced Bullous Pemphigoid in Metastatic Merkel Cell Carcinoma Successfully Treated with Dupilumab
Grandhe N, Romero S, … senior author Durkin J
- 71223
Systemic Sclerosis Poses Significant Patient and Hospital Burden: Analysis of Hospital Outcomes
Jaramillo C, Maltese A, … senior author Agarwal S
- 72000
- 72156
Geographic Variation in Dermatomyositis Prevalence Across U.S. Latitude Bands
Burke O, Bilik S, … senior author Elman S
- 72602
Real-world evidence of dupilumab’s efficacy in reducing autoantibodies to bullous pemphigoid antigens
Karpoff K, Patel A, … senior author Lebwohl M
- 72731
Clinically meaningful thresholds for percent change in CLASI-A scores in adults with cutaneous manifestations of lupus: A post-hoc analysis of Phase 2 WILLOW study
Werth V, Chong BF, … senior author Kamudoni P
- 72798
The pathogenic role of T cell subsets in the pathogenesis of bullous pemphigoid
Yan T, Li J, … senior author Zhang Z
- 72811
Navigating Immune Checkpoint Inhibitor Therapy in Patients with Dermatomyositis
Martin M, Ristianto ZA, … senior author Femia A
- 73096
Emerging Approaches to Wound Care in Bullous Pemphigoid: A Systematic Review
Jacoby T, Yee D, Isseroff R
- 73114
- 73447
Risk of Bullous Pemphigoid in Patients Treated With GLP-1 Receptor Agonists and Other Diabetes Medications: A Retrospective Cohort Study
Shen C, Vazquez T, … senior author Ellebrecht C
- 73543
- 73635
Real-World Effectiveness and Safety of Dupilumab in Bullous Pemphigoid: A Systematic Literature Review
Werth V, Pan M, … senior author Ge W
- 73738
- 73740
- 73760
Impact of MDA5 Autoantibody Status on Hospitalization Outcomes in Dermatomyositis-Associated ILD Exacerbations: Experience from a U.S. Tertiary Care Center
Niknejad K, Spangenberg A, … senior author Kang J
- 73934
Incidence of Systemic Malignancies in Localized and Systemic Scleroderma in Quebec, Canada: A Population-Based Study
Muha J, Joly-Chevrier M, … senior author Netchiporouk E
- 73955
Dupilumab for Eosinophilic Fasciitis: A Retrospective Study
Feng A, French M, … senior author Haemel A
- 73958
Severe Presentations of Cutaneous Lupus in Patients on Immune Checkpoint Inhibitors (ICIs)
Schwierking S, Brokamp G, … senior author Dulmage B
- 74612
Comparative Incidence of Bullous Pemphigoid in Patients Treated with DPP-4 Inhibitors Versus Metformin: A Retrospective Cohort Study
Cavanagh M, Villa G, … senior author Wilkerson M
- 75236
Computational Profiling in Pemphigus Vulgaris Identifies Predictive Autoantibody Biomarkers
Hoffman V, Schwartz RR, … senior author Sinha AA
- 75450
Characteristics, Management, and Outcomes of Cutaneous Malignancies Arising from Discoid Lupus Erythematosus: A Systematic Review
Shojaei D, Masoudi R, … senior author Khosravi T
- 75505
Complement Levels are Differentially Elevated in Autoimmune Bullous Disease: Insights from Immune Profiling
Kumar E, Lorenz M, … senior author Wei E
- 75591
UVA-1 Phototherapy for Morphea and Sclerosing Skin Disorders: Insights from a Decade-Long Retrospective Analysis
Liu W, Kalia S, … senior author Ahad T
- 75974
Triggers for epidermolysis bullosa acquisita flares: A multi-database retrospective pharmacovigilance study
Pathak G, Tan B, … senior author Murrell D
- 75990
Risk of malignancies in patients with bullous pemphigoid; a case-control study
Pathak G, Syed A, … senior author Murrell D
- 76002
COVID-19 Infection Increases Risk of Systemic Lupus Erythematosus While Vaccination Decreases Risk: A Population-Based Cohort Study
Manduca S, Ristianto ZA, … senior author Femia A
- 76089
Mucous membrane pemphigoid in the United states: A cross-sectional study of the All of Us database
Pathak G, Pathak S, … senior author Brieva J
- 76107
- 76154
Characterizing vaccine-induced dermatomyositis: a retrospective analysis of the Vaccine Adverse Event Reporting System (VAERS)
Dhillon J, Pathak G, … senior author Rao B
- 76455
Development of Autoimmune Bullous Disorders in Patients Exposed to Radiation Therapy: A Systematic Review
Ghafoor A, Maazi M, … senior author Croitoru D
- 76519
Methylprednisolone blocks complement deposition in an ex vivo model of pemphigoid diseases
Tigges M, Piccini I, … senior author Ludwig RJ
- 76586
Refractory nasal pemphigus vegetans treated with dupilumab in a patient with multiple contraindications to first-line therapies
Smith CA, Wongvibulsin S, … senior author Holland VR
- 76612
Severe New-Onset Pemphigus Vulgaris Following COVID-19 Infection: A Case Report and Scoping Review
Villanueva A, Yang R, … senior author Wong T
- 76698
Evaluating Connections between Morphea, Malignancies, and Autoimmune Diseases
Ristianto Z, Martin M, Femia A
- 76779
- 76825
Comparision of clinical, immunological and therapeutic response in gliptin associated versus idiopathic bullous pemphigoid - a prospective study
Handa S, Kaushal I, … senior author Saikia U
- 76834
Effect of Biologics on Cardiovascular Event Risk in Dermatomyositis: A Propensity-Matched Analysis
Tolotta J, Ayub M, … senior author Subhadarshani S
- 76887
BHV-1450, an Ig-G4 selective MODE degrader, mitigates anti-Dsg3-mediated skin damage implicated in Pemphigus vulgaris
Yousuf H, Karagianni A, … senior author Gardin T
- 76933
A Retrospective Review of 29 Cases of Lupus Panniculitis in Hispanic Patients: Histologic and Demographic Insights
Rosario LT, Oliver Garcia V, … senior author Sanchez N
- 77036
Race-Related Differences in Health Outcomes Amongst Dermatomyositis Patients
Ahmed N, Kelly W, Christopher-Stine L
- 77067
- 77089
Serum autoantibodies in dermatomyositis and systemic lupus erythematosus: A systematic review and meta-analysis
Mohsen S, Geng R, … senior author Piguet V
- 77175
Predictors of Treatment Refractory Bullous Pemphigoid
Penner S, Roberts BT, … senior author Mangold AR
- 77386
Demographic, Clinical Presentation, and Therapy of Patients with Dermatomyositis from an Academic-Based Dermatology Clinic in Puerto Rico
Medina-Figueroa M, Dubocq C, … senior author Martin-Garcia R
That's every abstract.